Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jemma Arakelyan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer|December 3, 2020
Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapiesJemma Arakelyan, Davit Zohrabyan, Philip A Philip
PLOS Global Public Health|July 1, 2024
Barriers to access to cancer care for patients from the conflict-affected region of the Nagorno-Karabakh Republic: A qualitative studyAlina Hovhannisyan, Celene Philip, Jemma Arakelyan, et al.
JCO Global Oncology|February 29, 2024
First Global Summit on War and Cancer: The Hidden Impact of War on Cancer-Urging Global Action for ChangeJemma Arakelyan, Tatevik Margaryan, Shushan Hovsepyan, et al.
Journal of the American Chemical Society|December 23, 2025
Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive ImmunogenicityJiao Xia Zou, Pavel A Ivanov-Rostovtsev, Jemma Arakelyan, et al.
JCO Global Oncology|August 14, 2020
Treatment and Outcomes of Colorectal Cancer in Armenia: A Real-World Experience From a Developing CountrySamvel Bardakhchyan, Sergo Mkhitaryan, Davit Zohrabyan, et al.
Inorganic Chemistry|May 18, 2023
Coordination of Ru(II)-Arene Fragments to Dipyridophenazine Ligands Leads to the Modulation of Their In Vitro and In Vivo Anticancer ActivityStefan Nikolić, Jemma Arakelyan, Vladimir Kushnarev, et al.
Cureus|June 10, 2022
An Update to Hallmarks of CancerSwapna Ravi, Antonio M Alencar, Jemma Arakelyan, et al.
Pharmaceutics|November 27, 2025
Bis-Oxadiazole Assemblies as NO-Releasing Anticancer AgentsEgor M Matnurov, Irina A Stebletsova, Alexander A Larin, et al.
Journal of Medicinal Chemistry|November 10, 2025
Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum ChemotherapyDarren F Beirne, Jemma Arakelyan, Matteo Forner, et al.
JCO Global Oncology|January 30, 2025
Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited SettingsElen Baloyan, Davit Zohrabyan, Liana Safaryan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer|December 3, 2020
Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapiesJemma Arakelyan, Davit Zohrabyan, Philip A Philip
PLOS Global Public Health|July 1, 2024
Barriers to access to cancer care for patients from the conflict-affected region of the Nagorno-Karabakh Republic: A qualitative studyAlina Hovhannisyan, Celene Philip, Jemma Arakelyan, et al.
JCO Global Oncology|February 29, 2024
First Global Summit on War and Cancer: The Hidden Impact of War on Cancer-Urging Global Action for ChangeJemma Arakelyan, Tatevik Margaryan, Shushan Hovsepyan, et al.
Journal of the American Chemical Society|December 23, 2025
Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive ImmunogenicityJiao Xia Zou, Pavel A Ivanov-Rostovtsev, Jemma Arakelyan, et al.
JCO Global Oncology|August 14, 2020
Treatment and Outcomes of Colorectal Cancer in Armenia: A Real-World Experience From a Developing CountrySamvel Bardakhchyan, Sergo Mkhitaryan, Davit Zohrabyan, et al.
Inorganic Chemistry|May 18, 2023
Coordination of Ru(II)-Arene Fragments to Dipyridophenazine Ligands Leads to the Modulation of Their In Vitro and In Vivo Anticancer ActivityStefan Nikolić, Jemma Arakelyan, Vladimir Kushnarev, et al.
Cureus|June 10, 2022
An Update to Hallmarks of CancerSwapna Ravi, Antonio M Alencar, Jemma Arakelyan, et al.
Pharmaceutics|November 27, 2025
Bis-Oxadiazole Assemblies as NO-Releasing Anticancer AgentsEgor M Matnurov, Irina A Stebletsova, Alexander A Larin, et al.
Journal of Medicinal Chemistry|November 10, 2025
Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum ChemotherapyDarren F Beirne, Jemma Arakelyan, Matteo Forner, et al.
JCO Global Oncology|January 30, 2025
Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited SettingsElen Baloyan, Davit Zohrabyan, Liana Safaryan, et al.
Pageof 2